NMDA receptor subunit composition determines beta-amyloid-induced neurodegeneration and synaptic loss

Cell Death and Disease

Volumn 4, Issue 4, 2013, Pages

  Tackenberg, C ^a   Grinschgl, S ^a   Trutzel, A ^a   Santuccione, A C ^a   Frey, M C ^a   Konietzko, U ^a   Grimm, J ^b   Brandt, R ^c   Nitsch, R M ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Neurimmune Therapeutics   (Switzerland)

^c UNIVERSITY OF OSNABRÜCK   (Germany)

Author keywords

A ; Amyloid beta; Dendritic spine; Neurodegeneration; NMDA receptor; Tau

Indexed keywords

AMYLOID BETA PROTEIN; CASPASE 3; GLYCOGEN SYNTHASE KINASE 3BETA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; TAU PROTEIN;

ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CONTROLLED STUDY; DENDRITIC SPINE; ENZYME ACTIVITY; HIPPOCAMPUS; IMMUNOBLOTTING; INHIBITION KINETICS; MOUSE; NERVE CELL; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SENSORY SYSTEM PARAMETERS; SYNAPTIC LOSS; TOXICITY; WILD TYPE;

AMYLOID BETA-PEPTIDES; ANIMALS; APOPTOSIS; CASPASE 3; CELLS, CULTURED; DENDRITIC SPINES; GLYCOGEN SYNTHASE KINASE 3; HIPPOCAMPUS; HUMANS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NEURONS; PHOSPHORYLATION; RECEPTORS, N-METHYL-D-ASPARTATE; TAU PROTEINS;

MUS MUSCULUS;

EID: 84876903457     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.129     Document Type: Article

References (53)

1. Jung T, Catalgol B, Grune T. The proteasomal system. Mol Aspects Med 2009; 30: 191-296.
2. Rechsteiner M, Hill CP. Mobilizing the proteolytic machine: Vell biological roles of proteasome activators and inhibitors. Trends Cell Biol 2005; 15: 27-33.
3. Komander D. The emergin complexity of protein ubiquitination. Biochem Soc Trans 2009; 37: 937-953.
4. Gaczynska M, Rock KL, Goldberg AL. Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 1993; 365: 264-267.
5. Preckel T, Fung-Leung WP, Cai Z, Vitiello A, Salter-Cid L, Winqvist O et al. Impaired immunoproteasome assembly and immune responses in PA28-/-mice. Science 1999; 286: 2162-2165.
6. Rivett AJ, Bose S, Brooks P, Broadfoot KI. Regulation of proteasome complexes by gamma-interferon and phosphorylation. Biochimie 2001; 83: 363-366.
7. Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature 2008; 451: 1069-1075.
8. Gamerdinger M, Kaya AM, Wolfrum U, Clement AM, Behl C. BAG3 mediates chaperonebased aggresome-targeting and selective autophagy of misfolded proteins. EMBO rep 2011; 12: 149-156.
9. Gamerdinger M, Hajieva P, Kaya AM, Wolfrum U, Hart FU, Behl C. Protein quality control during aging involves recruitment of the macroautophagy pathway by BAG3. EMBO J 2009; 28: 889-901.
10. Takayama S, Reed JC. Molecular chaperone targeting and regulation by BAG family proteins. Nat Cell Biol 2001; 3: E237-E241.
11. Behl C. BAG3 and friends: Vo-chaperones in selective autophagy during aging and disease. Autophagy 2011; 7: 795-798.
12. Packham G, Brinimeli M, Cleveland JL. Mammalian cells express two 28. differently localized Bag-1 isoforms generated by alternative translation initiation. Biochem J 1997; 328: 807-813.
13. Groll M, Huber R. Inhibitors of the eukaryotic 20S proteasome core particle: A structural approach. Biochim Biophys Acta 2004; 1695: 33-44.
14. Bjørkøy G, Lamark T, Brech A, Outzen H, Perander M, Øvervatn A et al. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtininduced cell death. J Cell Biol 2005; 171: 603-614.
15. Klionsky DJ, Cuervo AM, Seglen PO. Methods for monitoring autophagy from yeast to human. Autophagy 2007; 3: 181-206.
16. Pankiv S, Hoyvarde Clausen T, Lamark T, Brech A, Bruun JA et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 2007; 282: 24131-24145.
17. Tan JM, Wong ES, Kirkpatrick DS, Pletnikova O, Ko HS, Tay SP et al. Lysine 63-linked ubiquitination promotes the formation and autophagic clearance of protein inclusions associated with neurodegenerative diseases. Hum Mol Genet 2008; 17: 431-439.
18. Lim KL, Lim GG. K63-linked ubiquitination and neurodegeneration. Neurobiol Dis 2011; 43: 9-16.
19. Yang J, Takahashi Y, Cheng E, Liu J, Terranova PF, Zhao B et al. GSK-3b promotes cell survival by modulating Bif-1-dependent autophagy and cell death. J Cell Sci 2010; 123: 861-870.
20. Haenssen KK, Caldwell SA, Shahriari KS, Jackson SR, Whelan KA, Klein-Szanto AJ et al. ErbB2 requires integrin alpha5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells. J Cell Sci 2010; 123: 1373-1382.
21. Grimes CA, Jope RS. The multifaceted roles of glycogen synthase kinase 3 beta in cellular signaling. Prog Neurobiol 2001; 65: 391-426.
22. Johnsen A, France J, Sy MS, Harding CV. Down-regulation of the transporter for antigen presentation, proteasome subunits, and class I major histocompatibility complex in tumor cell lines. Cancer Res 1998; 58: 3660-3667.
23. Kageshita T, Hirai S, Ono T, Hicklin DJ, Ferrone S. Down-regulation of HLA class I antigen processing molecules in malignant melanoma: Association with disease progression. Am J Pathol 1999; 154: 745-754.
24. Meidenbauer N, Zippelius A, Pittet MJ, Laumer M, Vogl S, Heymann J et al. High frequency of functionally active Melan-aspecific T cells in a patient with progressive immunoproteasome-deficient melanoma. Cancer Res 2004; 64: 6319-6326.
25. Heink S, Fricke B, Ludwig D, Kloetzel PM, Krüger E. Tumor cell lines expressing the proteasome subunit isoform LMP7E1 exhibit immunoproteasome deficiency. Cancer Res 2006; 66: 649-652.
26. Fellerhoff B, Gu S, Laumbacher B, Nerlich AG, Weiss EH, Glas J et al. The LMP7-K allele of the immunoproteasome exhibits reduced transcript stability and predicts high risk of colon cancer. Cancer Res 2011; 71: 7145-7154.
27. Kraft C, Peter M, Hofmann K. Selective autophagy: Ubiquitin-mediated recognition and beyond. Nat Cell Biol 2010; 12: 836-841.
28. Carra S, Seguin SJ, Landry J. HspB8 and Bag3: A new chaperone complex targeting misfolded proteins to macroautophagy. Autophagy 2008; 4: 237-239.
29. Tyedmers J, Mogk A, Bukau B. Cellular strategies for controlling protein aggregation. Nat Rev Mol Cell Biol 2010; 11: 777-788.
30. Kim PK, Hailey DW, Mullen RT, Lippincott-Schwartz J. Ubiquitin signals autophagic degradation of cytosolic proteins and peroxisomes. Proc Natl Acad Sci 2008; 105: 20567-20574.
31. Komatsu M, Waguri S, Koike M, Sou YS, Ueno T, Hara T et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 2007; 131: 1149-1163.
32. Adhikari A, Chen ZJ. Diversity of polyubiquitin chains. Dev Cell 2009; 16: 485-486.
33. Seibenhener ML, Babu JR, Geetha T, Wong HC, Krishna NR, Wooten MW. Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. Mol Cell Biol 2004; 24: 8055-8068.
34. Olzmann JA, Li L, Chudaev MV, Chen J, Perez FA, Palmiter RD et al. Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6. J Cell Biol 2007; 178: 1025-1038.
35. Kirkin V, McEwan DG, Novak I, Dikic I. A role for ubiquitin in selective autophagy. Mol Cell 2009; 34: 259-269.
36. Johansen T, Lamark T. Selective autophagy mediated by autophagic adapter proteins. Autophagy 2011; 7: 279-296.
37. Choi CH, Lee BH, Ahn SG, Oh SH. Proteasome inhibition-induced p38 MAPK/ERK signaling regulates autophagy and apoptosis through the dual phosphorylation of glycogen synthase kinase 3b. Biochem Biophys Res Commun 2012; 418: 759-764.
38. Gavilán MP, Pintado C, Gavilán E, Jiménez S, Ríos RM, Vitorica J et al. Dysfunction of the unfolded protein response increases neurodegeneration in aged rat hippocampus following proteasome inhibition. Aging Cell 2009; 8: 654-665.
39. Milani M, Rzymski T, Mellor HR, Pike L, Bottini A, Generali D et al. The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib. Cancer Res 2009; 69: 4415-4423.
40. Benbrook DM, Long A. Integration of autophagy, proteasomal degradation, unfolded protein response and apoptosis. Exp Oncol 2012; 34: 286-297.
41. Rouschop KM, Wouters BG. Regulation of autophagy through multiple independent hypoxic signaling pathways. Curr Mol Med 2009; 9: 417-424.
42. Rzymski T, Milani M, Pike L, Buffa F, Mellor HR, Winchester L et al. Regulation of autophagy by ATF4 in response to severe hypoxia. Oncogene 2010; 29: 4424-4435.
43. Cook KL, Shajahan AN, Clarke R. Autophagy and endocrine resistance in breast cancer. Expert Rev Anticancer Ther 2011; 11: 1283-1294.
44. Boatright KM, Salvesen GS. Mechanisms of caspase activation. Curr Opin Cell Biol 2003; 15: 725-731.
45. Muñoz-Pinedo C, Ruiz-Ruiz C, Ruiz de Almodó var C, Palacios C, López-Rivas A. Inhibition of glucose metabolism sensitizes tumor cells to death receptor-triggered apoptosis through enhancement of death-inducing signaling complex formation and apical procaspase-8 processing. J Biol Chem 2003; 278: 12759-12768.
46. Hughes MA, Harper N, Butterworth M, Cain K, Cohen GM, MacFarlane M. Reconstitution of the death-inducing signaling complex reveals a substrate switch that determines CD95-mediated death or survival. Mol Cell 2009; 35: 265-279.
47. Lee JS, Li Q, Lee JY, Lee SH, Jeong JH, Lee HR et al. FLIP mediated autophagy regulation in cell death control. Nat Cell Biol 2009; 11: 1355-1362.
48. Laussmann MA, Passante E, Düssmann H, Rauen JA, Wü rstle ML, Delgado ME et al. Proteasome inhibition can induce an autophagy dependent apical activation of caspase-8. Cell Death Differ 2011; 18: 1584-1597.
49. Parr C, Carzaniga R, Gentleman SM, Van Leuven F, Walter J, Sastre M. Glycogen synthase kinase 3 inhibition promotes lysosomal biogenesis and autophagic degradation of the amyloid-b precursor protein. Mol Cell Biol 2012; 32: 4410-4418.
50. Gavilán MP, Pintado C, Gavilán E, García-Cuervo LM, Castaño A, Ríos RM et al. Age-related differences in the dynamics of hippocampal proteasome recovery. J Neurochem 2012; 123: 635-644.
51. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990; 82: 1107-1112.
52. Keepers YP, Pizao PE, Peters GJ, van Ark-Otte J, Winograd B, Pinedo HM. Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing. Eur J Cancer 1991; 27: 897-900.
53. Gavilán MP, Pintado C, Gavilán E, Jiménez S, Ríos RM, Vitorica J et al. Dysfunction of the unfolded protein response increases neurodegeneration in aged rat hippocampus following proteasome inhibition. Aging Cell 2009; 8: 654-665.